All Content Clinical Leader

  1. 3 FDA Approvals In 2025 That Shift The Landscape For 2026 1/20/2026

    In this presentation, Precision’s Chief Medical Officer and former FDA Director, Division of Oncology 2, Harpreet Singh, MD breaks down 3 FDA approvals from last year that are impacting 2026.

  2. "Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials 1/20/2026

    In this Q&A, Acumen Pharmaceuticals shares findings from its Alzheimer's recruitment study, highlighting what efforts proved the most fruitful.

  3. Endpoints, Procedures, And Deviations Are On The Rise — Why? 1/20/2026

    SCRS Chief Site Success Officer Jimmy Bechtel, MBA, and Tufts CSDD Executive Director Ken Getz, MBA, discuss why they're on the rise explore ways to address, and even accept, them. 

  4. Navigating FDA's New AI Systems: Practical Tips For Regulatory Success 1/19/2026

    AI-assisted reviews are changing FDA submissions. In part two of this series, discover how sponsors can address and even preempt regulatory and legal concerns.

  5. AI At The FDA: Legal Implications And Strategic Considerations For Drug Developers 1/19/2026

    AI-assisted reviews are changing FDA submissions. In part one of this two-part series, familiarize yourself with the FDA's use of AI and key legal concerns it raises.

  6. What the FDA Looks For In Global Development Programs Today 1/16/2026

    Mastering the complexities of multi-regional clinical trials requires aligning global data with evolving regulatory expectations to ensure treatment consistency and successful drug approval.

  7. Beyond The Benchmark: Innovative Trial Designs Transform Research 1/15/2026

    Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.

  8. Site Management And Oversight Become Must-Haves For Successful Sites 1/15/2026

    Site management and site oversight are often used interchangeably in clinical research, but they mean different things. Explore their roles and importance in ensuring successful sites and trials.

  9. Could Moving To This Swiss Life Sciences Hub Be In Your Company's Future? 1/15/2026

    Basel Area Business & Innovation CEO Christof Klöpper discusses how the Basel Area Life Sciences Supercluster supports discovery through commercialization.

  10. Empower Your Trial With Data And Evidence 1/14/2026

    Fuel your clinical development and decision-making with insights from fit-for-purpose data and evidence.